ArticleJournal of multidisciplinary healthcare2024
Association Between Dietary Selenium Intake and Kidney Stones Disease Among Patients with Metabolic Syndrome: A Cross-Sectional Study from the NHANES Database.
Article in Journal of multidisciplinary healthcare, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Interpretable Machine Learning for Predicting Metabolic Syndrome-Kidney Stone Disease Comorbidity: The Role of Dietary Micronutrients.Food science & nutrition · 2026Article
- Association between the Zhejiang University index and kidney stone risks in US adults: evidence from NHANES 2007-2018.American journal of clinical and experimental urology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Clinically, metabolic syndrome (MetS) is associated with the formation and relapse of kidney stones diseases (KSD). In the general population, dietary selenium can reduce renal damage by reducing oxidative stress and other physiological pathways. Less is known, however, about the association between dietary selenium and KSD in patients with MetS. Objective: The present study's purpose is to evaluate the association between dietary selenium intake and the odds of KSD in MetS populations. Methods: Data of MetS patients aged ≥20 years were extracted from the National Health and Nutrition Examination Survey (NHANES) database (2007-2018). The information of dietary selenium intake was obtained by 24-hour dietary recall interview. Weighted univariable and multivariate logistic regression analyses were used to evaluate the association of selenium intake with KSD in MetS patients and described as odds ratios (ORs) and 95% confidence intervals (CIs). Subgroup analysis was performed to further discuss this association based on age, gender, and MetS component. Results: In total, 6,073 patients were included, with 766 (12.61%) KSD cases. After adjusting for covariates, high dietary selenium intake was related to lower odds of KSD in MetS patients (OR = 0.70, 95% CI = 0.50-0.97), especially in females (OR = 0.61, 95% CI = 0.39-0.96), those aged <65 years (OR = 0.53, 95% CI = 0.35-0.80), without a history of hypertriglyceridemia (OR = 0.61, 95% CI = 0.40-0.93) and with a history of hypertension (OR = 0.57, 95% CI = 0.38-0.84), diabetes (OR = 0.68, 95% CI = 0.46-0.99) or central obesity (OR = 0.67, 95% CI = 0.48-0.95). Conclusion: From this cross-sectional study, we observed that, among patients with MetS, high dietary selenium intake is associated with lower odds of KSD, implying a potential nutritional strategy for preventing KSD in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.